トランスフェクション技術の市場規模、シェア、成長分析、製品別、方法別、用途別、エンドユーザー別、地域別 - 産業予測、2024年～2031年

世界のトランスフェクション技術の市場規模は、2022年に11億米ドルとなり、2023年の12億米ドルから、2031年までには26億9,000万米ドルに成長し、予測期間（2024年～2031年）のCAGRは9.4％で成長する見通しです。

バイオ医薬品市場は、慢性疾患の有病率の上昇と個別化医薬品の需要増に牽引されて大きく成長しています。この拡大の中心となっているのが、バイオ医薬品の開発と製造におけるトランスフェクション技術の極めて重要な役割です。遺伝子治療分野では、遺伝性疾患やがんへの対処を目的とした急速な進歩が見られ、標的遺伝子を確実に導入するためのウイルス送達技術への依存が高まっています。継続的な研究開発により、革新的なトランスフェクション試薬、装置、方法論が生み出され、細胞毒性効果を最小限に抑え、細胞遊走を改善しながらトランスフェクション効率を高めています。このような技術革新の急増は、分子生物学および細胞生物学における研究活動の活発化によって後押しされ、学術機関、研究所、製薬会社が創薬や機能ゲノミクスのためのトランスフェクション技術に投資するように促しています。競合情勢は、主要企業が優れた製品性能、信頼性、使いやすさ、価格設定、顧客情勢を通じて差別化を図っていることを特徴としています。さらに、規制の枠組みは、特に遺伝子治療と臨床応用に関する市場力学に大きく影響します。業界が発展するにつれ、技術的進歩、研究投資、規制遵守の相互作用がバイオ医薬品セクターの成長軌道を形成し続け、バリューチェーン全体の利害関係者に有望な機会を示唆すると思われます。

目次

イントロダクション

• 調査の目的
• 調査範囲
• 定義

調査手法

• 情報調達
• 二次データと一次データの方法
• 市場規模予測
• 市場の前提条件と制限

エグゼクティブサマリー

• 世界市場の見通し
• 供給と需要の動向分析
• セグメント別機会分析

市場力学と見通し

• 市場概要
• 市場規模
• 市場力学
  • 促進要因と機会
  • 抑制要因と課題
• ポーター分析と影響
  • 競争企業間の敵対関係
  • 代替品の脅威
  • 買い手の交渉力
  • 新規参入業者の脅威
  • 供給企業の交渉力

主要な市場の考察

• 主要な成功要因
• 競合の程度
• 主要な投資機会
• 市場エコシステム
• 技術の進歩
• 規制情勢
• バリューチェーン分析
• ケーススタディ分析
• PESTEL分析
• マクロ経済指標
• 市場の魅力指数

トランスフェクション技術市場規模：製品別・CAGR（2024年～2031年）

• 市場概要
• キット
• 装置

トランスフェクション技術市場規模：方法別・CAGR（2024年～2031年）

• 市場概要
• 物理的トランスフェクション
  • エレクトロポレーション
  • バイオリスティックトランスフェクション/遺伝子銃
  • マイクロインジェクション
  • その他の物理的トランスフェクション法
• 生化学に基づくトランスフェクション
  • リポフェクション
  • リン酸カルシウムトランスフェクション
  • カチオンポリマートランスフェクション
  • DEAE-デキストラントランスフェクション
  • 磁気支援トランスフェクション
  • デンドリマーを介したトランスフェクション
• ウイルスベクターベースのトランスフェクション
• 共トランスフェクション

トランスフェクション技術市場規模：用途別・CAGR（2024年～2031年）

• 市場概要
• 生物医学調査
  • 遺伝子・タンパク質発現研究
  • がん調査
  • トランスジェニックモデル
• 治療の実施
  • バイオ医薬品
  • 電気免疫療法
  • 電気化学療法
• タンパク質生産
• 細胞ベースのマイクロアレイ

トランスフェクション技術市場規模：エンドユーザー別・CAGR（2024年～2031年）

• 市場概要
• 製薬・バイオテクノロジー企業
• CROとCDMO
• 学術研究機関
• その他

トランスフェクション技術市場規・CAGR（2024年～2031年）

• 北米
  • 米国
  • カナダ
• 欧州
  • 英国
  • ドイツ
  • スペイン
  • フランス
  • イタリア
  • その他欧州地域
• アジア太平洋
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋
• ラテンアメリカ
  • ブラジル
  • その他ラテンアメリカ地域
• 中東・アフリカ
  • GCC諸国
  • 南アフリカ
  • その他中東・アフリカ

競合情報

• 上位5社の比較
• 主要企業の市場ポジショニング（2023年）
• 主要な市場企業が採用した戦略
• 市場の最近の動向
• 企業の市場シェア分析（2023年）
• 主要企業の企業プロファイル
  • 会社概要
  • 製品ポートフォリオ分析
  • 企業のセグメント別シェア分析
  • 収益の前年比比較（2021年～2023年）

主要企業プロファイル

• Thermo Fisher Scientific Inc.（US）
• Bio-Rad Laboratories, Inc.（US）
• QIAGEN（Netherlands）
• Merck KGaA（Germany）
• Sartorius AG（Polyplus）（Germany）
• Lonza（Switzerland）
• F. Hoffmann-La Roche Ltd（Switzerland）
• Agilent Technologies, Inc.（US）
• MaxCyte（US）
• Revvity（US）
• Takara Bio Inc.（Japan）
• Promega Corporation（US）
• Danaher Corporation（US）
• BOC Sciences（US）
• RJH BIOSCIENCES（Canada）
• Synvolux（Netherlands）
• Altogen Biosciences（US）
• BioIVT（US）
• Incella GmbH（Germany）
• InvivoGen（France）

結論と提言

Global Transfection Technologies Market size was valued at USD 1.10 Billion in 2022 and is poised to grow from USD 1.2 Billion in 2023 to USD 2.69 Billion by 2031, growing at a CAGR of 9.4% in the forecast period (2024-2031).

The biopharmaceutical market is witnessing significant growth driven by the rising prevalence of chronic diseases and an increasing demand for personalized medicines. Central to this expansion is the pivotal role of transfection technologies in the development and manufacturing of biopharmaceuticals. The gene therapy sector is experiencing rapid advancements aimed at addressing genetic disorders and cancer, with a growing reliance on viral delivery technologies to ensure targeted gene delivery. Continuous research and development are yielding innovative transfection reagents, devices, and methodologies, enhancing transfection efficiency while minimizing cytotoxic effects and improving cell migration. This surge in innovation is fueled by heightened research activity in molecular and cell biology, prompting academic institutions, research laboratories, and pharmaceutical companies to invest in transfection technologies for drug discovery and functional genomics. The competitive landscape is characterized by leading companies striving for differentiation through superior product performance, reliability, user-friendliness, pricing, and customer support. Moreover, regulatory frameworks significantly influence market dynamics, particularly concerning gene therapy and clinical applications. As the industry evolves, the interplay between technological advancements, investment in research, and regulatory compliance will continue to shape the growth trajectory of the biopharmaceutical sector, signaling promising opportunities for stakeholders across the value chain.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Transfection Technologies market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Transfection Technologies Market Segmental Analysis

Global Transfection Technologies Market is segmented by Product, Method, Application, End User and region. Based on Product, the market is segmented into Kits, Equipment. Based on Method, the market is segmented into Physical transfection (Electroporation, Biolistic transfection/ gene guns, Microinjection, Other physical transfection methods), Biochemical-based transfection (Lipofection, Calcium phosphate transfection, Cationic polymer transfection, DEAE-dextran transfection, Magnet-assisted transfection, Dendrimer-mediated transfection), Viral-vector based transfection, Cotransfection. Based on application, the market is segmented into Biomedical research (Gene and protein expression studies, Cancer research, Transgenic models), Therapeutic delivery (Biotherapeutics, Electroimmunotherapy, Electrochemotherapy), Protein production, Cell-based microarrays. Based on end user, the market is segmented into Pharmaceutical and biotechnology companies, CROs and CDMOs, Academic and research institutes, Other. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Driver of the Global Transfection Technologies Market

The Global Transfection Technologies market is significantly driven by the increasing introduction of innovative products. Co-transfection, which entails the simultaneous introduction of multiple nucleic acids into a eukaryotic cell, exemplifies this trend, showcasing a variety of methodologies including the use of plasmid DNA, combinations of siRNA and plasmid DNA, and multiple miRNAs within a single cell. This technique aims to integrate several foreign genes into host cells, facilitating applications such as the creation of viral or hybrid viral constructs that incorporate multiple plasmid DNA segments. Notable examples include the generation of lentivirus utilizing diverse plasmids-transfer, envelope, and packaging vectors-within HEK293 cells, highlighting the potential advancements in gene delivery systems.

Restraints in the Global Transfection Technologies Market

Restraints in the Global Transfection Technologies market include the escalating costs and complexities associated with certain sterilization methods. Techniques that require specialized equipment or proprietary components can be financially burdensome and challenging to execute. The initial investment, combined with ongoing maintenance expenses and the necessity for specialized expertise, may pose significant barriers, particularly for academic researchers and small biotechnology firms that often operate within tight budget constraints. As a result, these financial and operational hurdles can limit access to essential transfection technologies, potentially stifling innovation and progress within the field.

Market Trends of the Global Transfection Technologies Market

The global transfection technologies market is witnessing a significant trend toward the adoption of advanced delivery systems for nucleic acids. Innovations such as lipid nanoparticles, polymer-based carriers, and viral vectors are increasingly preferred due to their superior transfection efficiency, enhanced cellular targeting, and minimized cytotoxic effects compared to traditional methods. This shift is particularly evident in sectors such as gene therapy, drug delivery, and genome editing, where precision and safety are paramount. The ongoing research in biomedical applications underscores the urgency to design effective viral technologies, signaling a robust demand that is reshaping the landscape of transfection technologies worldwide.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Driver & Opportunities
  • Restraints & Challenges
• Porters Analysis & Impact
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Technological Advancement
• Regulatory Landscape
• Value Chain Analysis
• Case Study Analysis
• PESTEL Analysis
• Macro-Economic Indicators
• Market Attractiveness Index

Global Transfection Technologies Market Size by Product & CAGR (2024-2031)

• Market Overview
• Kits
• Equipment

Global Transfection Technologies Market Size by Method & CAGR (2024-2031)

• Market Overview
• Physical transfection
  • Electroporation
  • Biolistic transfection/ gene guns
  • Microinjection
  • Other physical transfection methods
• Biochemical-based transfection
  • Lipofection
  • Calcium phosphate transfection
  • Cationic polymer transfection
  • DEAE-dextran transfection
  • Magnet-assisted transfection
  • Dendrimer-mediated transfection
• Viral-vector based transfection
• Cotransfection

Global Transfection Technologies Market Size by Application & CAGR (2024-2031)

• Market Overview
• Biomedical research
  • Gene and protein expression studies
  • Cancer research
  • Transgenic models
• Therapeutic delivery
  • Biotherapeutics
  • Electroimmunotherapy
  • Electrochemotherapy
• Protein production
• Cell-based microarrays.

Global Transfection Technologies Market Size by End User & CAGR (2024-2031)

• Market Overview
• Pharmaceutical and biotechnology companies
• CROs and CDMOs
• Academic and research institutes
• Other

Global Transfection Technologies Market Size & CAGR (2024-2031)

• North America, (Product, Method, Application, End User)
  • US
  • Canada
• Europe, (Product, Method, Application, End User)
  • UK
  • Germany
  • Spain
  • France
  • Italy
  • Rest of Europe
• Asia-Pacific, (Product, Method, Application, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia Pacific
• Latin America, (Product, Method, Application, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa, (Product, Method, Application, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2023
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

• Thermo Fisher Scientific Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• QIAGEN (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck KGaA (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sartorius AG (Polyplus) (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lonza (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• F. Hoffmann-La Roche Ltd (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agilent Technologies, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MaxCyte (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Revvity (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Takara Bio Inc. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Promega Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BOC Sciences (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• RJH BIOSCIENCES (Canada)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Synvolux (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Altogen Biosciences (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BioIVT (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Incella GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• InvivoGen (France)
  • Conclusio Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendation